Insmed's Series A - II Round

Insmed raised a round of funding on April 01, 1997.

Insmed is a biopharmaceutical company dedicated to improving the lives of patients battling serious rare diseases. Insmed is focused on the development and commercialization of ARIKAYCE, or liposomal …

Articles about Insmed's Series A - II Round: